NEWS
January 15, 2016
Roche and Catalent team up in $600m conjugation tech deal
January 7, 2016
January 7, 2016
January 7, 2016
January 6, 2016
eFFECTOR Therapeutics Initiates Dosing in Phase 1/2 Clinical Trial of eFT508 in Solid Tumors
December 22, 2015
eFFECTOR Therapeutics Raises $40 Million Series B Financing
November 4, 2015
Gates Foundation, GSK, others back biotech in white-hot area of cancer
November 4, 2015
June 16, 2015
Zymergen Grabs $44M For “Designer” Microbes Tested by Robots
June 3, 2015
A Bay Area Startup Spins Lab-Grown Silk
May 12, 2015
Bay Area Fund, Aligned With UC, Raises New Cash To Seed Biotechs
May 12, 2015
Small but mighty VC doubles up with new biotech seed fund
October 3, 2014
April 29, 2014
Bristol-Myers Squibb Acquires iPierian, Inc.
October 29, 2013
Calithera BioSciences Nabs $35M for Cancer Drugs
May 21, 2013
Effector Therapeutics Raises $45M to Prove New Concept in Cancer
May 15, 2013
Bayer inks startup matchmaking deal with QB3, Mission Bay Capital
April 10, 2013
Catalent Biologics Expands Into ADCs Through Exclusive License With Redwood Bioscience
March 19, 2013
This Protein Could Change Biotech Forever
October 30, 2012
UCSF Spinout Principia Biopharma Thinking Big and Covalent
October 2, 2012
Startup Atreca Joins With Gates Foundation to Speed Vaccine Discovery
April 5, 2012
Mission Bay Capital Seeds Surgical Device Start-Up Magnamosis
September 8, 2011
Biopharma Venture Funds Are Stepping Up Where VC Firms Are Stepping Out
December 21, 2010
Expansion of Incubator Network, Seed Fund Among QB3 Priorities for 2011
September 16, 2010
New Venture Capital Firms In A Shrinking Industry (Part II)
July 7, 2010
Calithera, a UCSF Spinoff, Raises $40M to Develop Cancer Drugs
July 7, 2010
Mission Bay Capital invests in UCSF cancer therapy spinoff
April 26, 2010
Mission Bay Capital makes first investment, in UC biotech spinoff
April 25, 2010
UC targeted seed fund backs first startup
October 26, 2009
Mission Bay Capital Announces First Venture Fund